DC
Defender Capital’s Lineage Cell Therapeutics LCTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.16M | Buy |
6,785,177
+474,304
| +8% | +$430K | 2.09% | 12 |
|
2025
Q1 | $3.16M | Buy |
6,310,873
+347,525
| +6% | +$174K | 1.24% | 12 |
|
2024
Q4 | $3M | Buy |
5,963,348
+961,150
| +19% | +$483K | 1.1% | 12 |
|
2024
Q3 | $4.53M | Buy |
5,002,198
+29,223
| +0.6% | +$26.5K | 1.5% | 12 |
|
2024
Q2 | $4.96M | Buy |
4,972,975
+5,300
| +0.1% | +$5.29K | 1.69% | 12 |
|
2024
Q1 | $7.35M | Sell |
4,967,675
-2,000
| -0% | -$2.96K | 2.5% | 12 |
|
2023
Q4 | $5.42M | Sell |
4,969,675
-214,835
| -4% | -$234K | 1.9% | 12 |
|
2023
Q3 | $6.12M | Buy |
5,184,510
+74,800
| +1% | +$88.3K | 2.22% | 10 |
|
2023
Q2 | $7.2M | Sell |
5,109,710
-26,375
| -0.5% | -$37.2K | 2.48% | 10 |
|
2023
Q1 | $7.7M | Buy |
5,136,085
+42,550
| +0.8% | +$63.8K | 2.69% | 10 |
|
2022
Q4 | $5.96M | Sell |
5,093,535
-90,500
| -2% | -$106K | 2.41% | 10 |
|
2022
Q3 | $5.86M | Buy |
5,184,035
+52,100
| +1% | +$58.9K | 2.3% | 10 |
|
2022
Q2 | $8.11M | Buy |
5,131,935
+125,750
| +3% | +$199K | 3.18% | 10 |
|
2022
Q1 | $7.98M | Buy |
5,006,185
+8,315
| +0.2% | +$13.3K | 2.78% | 11 |
|
2021
Q4 | $12.2M | Buy |
4,997,870
+199,600
| +4% | +$489K | 3.93% | 9 |
|
2021
Q3 | $12.7M | Sell |
4,798,270
-238,450
| -5% | -$631K | 4.13% | 9 |
|
2021
Q2 | $14.4M | Buy |
5,036,720
+86,000
| +2% | +$245K | 4.77% | 9 |
|
2021
Q1 | $11.6M | Buy |
4,950,720
+214,730
| +5% | +$504K | 4.14% | 9 |
|
2020
Q4 | $8.34M | Sell |
4,735,990
-313,000
| -6% | -$551K | 3.63% | 8 |
|
2020
Q3 | $4.73M | Buy |
5,048,990
+402,700
| +9% | +$377K | 2.33% | 10 |
|
2020
Q2 | $4.04M | Buy |
4,646,290
+229,700
| +5% | +$200K | 2.38% | 9 |
|
2020
Q1 | $3.66M | Buy |
4,416,590
+439,545
| +11% | +$364K | 2.67% | 10 |
|
2019
Q4 | $3.54M | Buy |
3,977,045
+183,000
| +5% | +$163K | 3.14% | 8 |
|
2019
Q3 | $3.71M | Sell |
3,794,045
-325,755
| -8% | -$318K | 3.29% | 7 |
|
2019
Q2 | $4.27M | Sell |
4,119,800
-94,760
| -2% | -$98.2K | 3.45% | 7 |
|
2019
Q1 | $5.57M | Buy |
4,214,560
+230,090
| +6% | +$304K | 4.46% | 6 |
|
2018
Q4 | $3.63M | Buy |
+3,984,470
| New | +$3.63M | 3.46% | 6 |
|